Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
190,759,777
-
Share change
-
-419,159
-
Total reported value
-
$46,243,528,087
-
Put/Call ratio
-
123%
-
Price per share
-
$241.82
-
Number of holders
-
953
-
Value change
-
-$117,523,974
-
Number of buys
-
445
-
Number of sells
-
421
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q2 2016
As of 30 Jun 2016,
BIOGEN INC. - COM (BIIB) was held by
953 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
190,759,777 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, and Invesco Ltd..
This page lists
955
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.